Commercial Strategy for a Cardiovascular Digital Health Product

The innovation and business acceleration group of an F200 pharmaceutical company was preparing to launch a new cardiovascular device with an accompanying digital therapeutic product. Looking for a commercial strategy leader with digital health and medical device experience to own the commercial plan development, project timeline, and marketing plan for the digital product, they reached out to Business Talent Group.

BTG provided a seasoned life science executive with over 25 years of leadership experience in healthcare, biotechnology, and digital health, who had previously led the financing, development, approval, and launch of multiple innovative life science products, including cardiovascular digital therapies. The consultant conducted a competitive assessment, determined the appropriate commercial (payment and reimbursement) model for the product, developed both upstream and downstream marketing plans, and created a go-to-market launch plan.

Previous Article
Developing a Payer Value Proposition in Genetic Diagnostics
Developing a Payer Value Proposition in Genetic Diagnostics

A leading mid-cap genetic diagnostic company was preparing for an important product launch in the chronic k...

Next Article
Data and Analytics Expertise for a Company-Wide Transformation
Data and Analytics Expertise for a Company-Wide Transformation

A multinational life science data and analytics company was under new leadership and undergoing a structura...